117 related articles for article (PubMed ID: 1311067)
1. Prophylactic oral acyclovir in outbreaks of primary herpes simplex virus type 1 infection in a closed community.
Kuzushima K; Kudo T; Kimura H; Kido S; Hanada N; Shibata M; Nishikawa K; Morishima T
Pediatrics; 1992 Mar; 89(3):379-83. PubMed ID: 1311067
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations of primary herpes simplex virus type 1 infection in a closed community.
Kuzushima K; Kimura H; Kino Y; Kido S; Hanada N; Shibata M; Morishima T
Pediatrics; 1991 Feb; 87(2):152-8. PubMed ID: 1846235
[TBL] [Abstract][Full Text] [Related]
3. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
[TBL] [Abstract][Full Text] [Related]
4. Acyclovir and renal transplantation.
Pettersson E; Eklund B; Höckerstedt K; Salmela K; Ahonen J
Scand J Infect Dis Suppl; 1985; 47():145-8. PubMed ID: 3912970
[TBL] [Abstract][Full Text] [Related]
5. Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease.
Erard V; Wald A; Corey L; Leisenring WM; Boeckh M
J Infect Dis; 2007 Jul; 196(2):266-70. PubMed ID: 17570114
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
7. Recurrent herpes simplex virus hepatitis after liver retransplantation despite acyclovir therapy.
Longerich T; Eisenbach C; Penzel R; Kremer T; Flechtenmacher C; Helmke B; Encke J; Kraus T; Schirmacher P
Liver Transpl; 2005 Oct; 11(10):1289-94. PubMed ID: 16184558
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus in febrile neutropenic children undergoing chemotherapy for cancer: a prospective cohort study.
Ramphal R; Grant RM; Dzolganovski B; Constantin J; Tellier R; Allen U; Weitzman S; Matlow A; Petric M; Sung L
Pediatr Infect Dis J; 2007 Aug; 26(8):700-4. PubMed ID: 17848881
[TBL] [Abstract][Full Text] [Related]
9. Restriction endonuclease analysis of deoxyribonucleic acid (DNA) from genital herpes simplex virus type 2 isolates in Thailand.
Chantratita W; Yoosook C
Sex Transm Dis; 1990; 17(1):42-7. PubMed ID: 2154866
[TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus infection in cancer patients: prevention and treatment.
Tang IT; Shepp DH
Oncology (Williston Park); 1992 Jul; 6(7):101-6, 109; discussion 109-10. PubMed ID: 1322152
[TBL] [Abstract][Full Text] [Related]
11. A retrospective, case-control study of acyclovir resistance in herpes simplex virus.
Malvy D; Treilhaud M; Bouée S; Crochard A; Vallée D; El Hasnaoui A; Aymard M;
Clin Infect Dis; 2005 Aug; 41(3):320-6. PubMed ID: 16007528
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.
Tyler KL
Herpes; 2004 Jun; 11 Suppl 2():57A-64A. PubMed ID: 15319091
[TBL] [Abstract][Full Text] [Related]
13. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
[TBL] [Abstract][Full Text] [Related]
14. Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis.
Mejías A; Bustos R; Ardura MI; Ramírez C; Sánchez PJ
J Perinatol; 2009 Apr; 29(4):290-6. PubMed ID: 19194454
[TBL] [Abstract][Full Text] [Related]
15. A cluster of neonatal herpes simplex infections without mucocutaneous manifestations.
Amortegui AJ; Macpherson TA; Harger JH
Pediatrics; 1984 Feb; 73(2):194-8. PubMed ID: 6320084
[TBL] [Abstract][Full Text] [Related]
16. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
18. Prevention of herpes simplex virus infection by oral acyclovir after cardiac transplantation.
Carrier M; Pelletier GB; Cartier R; Leclerc Y; Pelletier LC
Can J Surg; 1992 Oct; 35(5):513-6. PubMed ID: 1393867
[TBL] [Abstract][Full Text] [Related]
19. Low-dose oral acyclovir for prevention of herpes simplex virus infection during OKT3 therapy.
Tang IY; Maddux MS; Veremis SA; Bauma WD; Pollak R; Mozes MF
Transplant Proc; 1989 Feb; 21(1 Pt 2):1758-60. PubMed ID: 2652575
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide sequence of thymidine kinase gene of sequential acyclovir-resistant herpes simplex virus type 1 isolates recovered from a child with Wiskott-Aldrich syndrome: evidence for reactivation of acyclovir-resistant herpes simplex virus.
Saijo M; Suzutani T; Itoh K; Hirano Y; Murono K; Nagamine M; Mizuta K; Niikura M; Morikawa S
J Med Virol; 1999 Aug; 58(4):387-93. PubMed ID: 10421406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
